Physician
Oregon Retina Specialists, LLC
Oregon Retina Specialists, LLC was paid $3.77M by Medicaid between Jan 2018 and Dec 2024, across 22 billing codes. Its largest line is J0178, Injection, aflibercept, 1 mg — 52% of everything it billed.
33Billing provider infoOREGON RETINA SPECIALISTS, LLC
MEDFORD, OR 97504
MEDFORD, OR 97504
33aNPI1285812123assigned 02/02/2008
33bProvider typeRetina Specialist (Ophthalmology) Physician
28Total paid$3.77M
24GClaims31,052
24DCodes billed22
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,560 | $129K | |
| 2019 | 3,989 | $284K | |
| 2020 | 3,675 | $480K | |
| 2021 | 5,266 | $521K | |
| 2022 | 5,717 | $720K | |
| 2023 | 5,232 | $912K | |
| 2024incomplete | 3,613 | $728K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 52% | 2,252 | 1,838 | $1.97M |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 17% | 458 | 385 | $636K |
| 67028 | Intravitreal injection of a pharmacologic agent | 9.2% | 6,598 | 5,200 | $348K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 5.2% | 3,614 | 3,224 | $198K |
| 92235 | 3.8% | 2,506 | 2,237 | $142K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.1% | 2,075 | 1,823 | $117K |
| 92134 | 2.8% | 5,889 | 5,150 | $106K | |
| J9035 | Injection, bevacizumab, 10 mg | 2.3% | 1,692 | 1,440 | $87K |
| 92250 | 1.8% | 3,397 | 2,994 | $70K | |
| J7999 | Compounded drug, not otherwise classified | <1% | 719 | 563 | $25K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 616 | 549 | $25K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 168 | 154 | $14K |
10 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 449 | $12K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 267 | $10K |
| J2778 | Injection, ranibizumab, 0.1 mg | <1% | 15 | $6K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 43 | $4K |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 19 | $0.00 |
| 1036F | 0% | 67 | $0.00 | |
| 4177F | 0% | 18 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 95 | $0.00 |
| G9744 | Patient not eligible due to active diagnosis of hypertension | 0% | 13 | $0.00 |
| 4040F | 0% | 82 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWANG, YUJEN (MEMBER)